if ABT expresses its intent to make dividends a priority, then i will stick with ABT. But i agree on selling ABBV. The reason i liked ABT in the first place was because it was highly diversified, plus had the Humira cash cow. Now ABBV is wholely dependent on Humira and is susceptible to any potential Humira shocks. Too many eggs in the Humira basket. If the new ABT doesn't commit to dividends, then it becomes a sell. Too bad....the old ABT had everything i liked in a company...high dividend, diversified income streams.